These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 3800301

  • 1. Preliminary evaluation of measurement of serum prostate-specific antigen level in detection of prostate cancer.
    Wang TY, Kawaguchi TP.
    Ann Clin Lab Sci; 1986; 16(6):461-6. PubMed ID: 3800301
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Tumor markers of prostate cancer--evaluation of serum PAP and PA].
    Miki M.
    Gan No Rinsho; 1985 May; 31(6 Suppl):664-9. PubMed ID: 2411965
    [Abstract] [Full Text] [Related]

  • 4. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
    Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E.
    N Engl J Med; 1987 Oct 08; 317(15):909-16. PubMed ID: 2442609
    [Abstract] [Full Text] [Related]

  • 5. [Measurement of serum PSA by DELFIA PSA kit and its application for mass screening. The Gunma Urological Oncology Study Group].
    Imai K, Watanabe K, Higashi H, Shinya H, Okamura K, Matsuo Y, Yazima H, Takezawa Y, Yamanaka H.
    Hinyokika Kiyo; 1993 Sep 08; 39(9):807-12. PubMed ID: 7692709
    [Abstract] [Full Text] [Related]

  • 6. [A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma].
    Bentvelsen FM, Bogdanowicz JF, Oosterom R, Schröder FH.
    Ned Tijdschr Geneeskd; 1990 Aug 18; 134(33):1596-600. PubMed ID: 1697651
    [Abstract] [Full Text] [Related]

  • 7. [Prostate-specific antigen. A new marker of prostatic pathology].
    Boccon-Gibod L, Géraud M, Dugué MA.
    Ann Urol (Paris); 1988 Aug 18; 22(3):206-10. PubMed ID: 2456714
    [Abstract] [Full Text] [Related]

  • 8. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
    Haukaas S, Skaarland E, Halvorsen OJ, Stensland E, Farstad M.
    Tidsskr Nor Laegeforen; 1990 Sep 30; 110(23):2990-3. PubMed ID: 1700496
    [Abstract] [Full Text] [Related]

  • 9. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
    Morote Robles J, de Torres Mateos JA.
    Arch Esp Urol; 1989 Sep 30; 42 Suppl 2():124-30. PubMed ID: 2484148
    [Abstract] [Full Text] [Related]

  • 10. [Value of serum PSA and PAP measurement with newly developed latex turbidimetric immunoassay].
    Akino H, Tsuka H, Okada K, Tsuchiya Y, Matsubara M, Arimura K.
    Hinyokika Kiyo; 1995 Jun 30; 41(6):439-45. PubMed ID: 7544063
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of prostate-specific antigen as a marker for adenocarcinoma of the prostate.
    Barak M, Mecz Y, Lurie A, Gruener N.
    J Lab Clin Med; 1989 May 30; 113(5):598-603. PubMed ID: 2469756
    [Abstract] [Full Text] [Related]

  • 12. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A, Ersev D, Turkeri L, Ilker Y, Simsek F, Kullu S, Akdas A.
    Prog Clin Biol Res; 1990 May 30; 357():129-34. PubMed ID: 1699237
    [Abstract] [Full Text] [Related]

  • 13. [The clinical use of the prostate-specific antigen in patients with prostatic cancer].
    Matveev BP, Sokolov AV, Bukharkin BV, Ledian KM, Tilk AE, Makarova GV.
    Urol Nefrol (Mosk); 1991 May 30; (4):8-12. PubMed ID: 1719686
    [Abstract] [Full Text] [Related]

  • 14. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
    Akimoto S, Akakura K, Shimazaki J.
    Hinyokika Kiyo; 1988 Aug 30; 34(8):1389-96. PubMed ID: 2461644
    [Abstract] [Full Text] [Related]

  • 15. Relative reliability of five serially measured markers for prognosis of progression in prostate cancer.
    Killian CS, Emrich LJ, Vargas FP, Yang N, Wang MC, Priore RL, Murphy GP, Chu TM.
    J Natl Cancer Inst; 1986 Feb 30; 76(2):179-85. PubMed ID: 2418245
    [Abstract] [Full Text] [Related]

  • 16. [Anatomoclinical and biologic correlations in prostatic pathology. Apropos of 150 case reports].
    Amiel J, Chevallier D, Peyrottes A, Benoliel J, Toubol J.
    Ann Urol (Paris); 1989 Feb 30; 23(6):528-30. PubMed ID: 2482700
    [Abstract] [Full Text] [Related]

  • 17. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
    Akimoto S, Ohki T, Ichikawa T, Akakura K, Shimazaki J.
    Hinyokika Kiyo; 1994 Nov 30; 40(11):987-93. PubMed ID: 7530404
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphatase.
    Dattoli M, Wallner K, True L, Cash J, Sorace R.
    Cancer; 2003 Feb 15; 97(4):979-83. PubMed ID: 12569596
    [Abstract] [Full Text] [Related]

  • 19. [The value of the serum level of the prostate-specific antigen in prostatic pathology].
    Théodon P, Rymer JC, Chopin D, Kouyoudjian JC, Abbou CC, Auvert J.
    Ann Urol (Paris); 1988 Feb 15; 22(3):199-205. PubMed ID: 2456713
    [Abstract] [Full Text] [Related]

  • 20. Prostate specific antigen. Experimental and clinical observations.
    Huber PR, Schnell Y, Hering F, Rutishauser G.
    Scand J Urol Nephrol Suppl; 1987 Feb 15; 104():33-9. PubMed ID: 2449722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.